LAS VEGAS, March 20, 2019 /PRNewswire/ -- Complex Regional Pain Syndrome total cases are expected to increase at a CAGR of 0.8% for the study period.
DelveInsight launched Complex Regional Pain Syndrome - Market Insights, Epidemiology and Market Forecast- 2028
"The epidemiology is segmented on the basis of gender and types. In terms of gender, females are more frequently affected by CRPS as compared to males, while in terms of types, CRPS I accounts for the maximum number of cases as compared to CRPS II".
The overall dynamics of Complex Regional Pain Syndrome market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Neridronate, BHV-5000, PPP001, AXS-02 and many others.
The CRPS treatment is restricted to palliative care and symptom-based interventions such as Non-opioid analgesics (Paracetamol, NSAIDs, Nefopam etc.), Weak opioid analgesics (Tramadol, Codeine/Acetaminophen, Opium/PCM etc.), Strong opioid analgesics, Co-analgesics (Corticosteroids, Antiepileptics, Antidepressants, Tricyclic Antidepressants, SNRIs, Bisphosphonate, IV Bisphosphonate, Calcitonin, Ketamine etc.), Local treatment (Joint infusion of corticosteroids, Lidocaine cream, Lidocaine patch, Capsaicin, NSAIDs etc.) and others (including Physiotherapy, surgery, Psychological interventions etc.) The key players in CRPS market are:
Get a demo of the report: https://bit.ly/2UPlTDC
And many others
Drugs covered
And many others
Table of contents
1 Key Insights
2 CRPS Market Overview at a Glance
3 Complex Regional Pain Syndrome Disease Background and Overview
4 CRPS Epidemiology and Patient Population
5 Complex Regional Pain Syndrome Total Cases In 7MM
6 United States CRPS Epidemiology
7 EU5 CRPS Epidemiology
7.1 Germany CRPS Epidemiology
7.2 France CRPS Epidemiology
7.3 Italy CRPS Epidemiology
7.4 Spain CRPS Epidemiology
7.5 United Kingdom CRPS Epidemiology
8 Japan CRPS Epidemiology
9 Complex Regional Pain Syndrome Treatment and Management
10 Complex Regional Pain Syndrome Unmet Needs
11 Complex Regional Pain Syndrome Emerging Therapies
11.1 Key Cross Competition
11.2 Neridronate: Abiogen Pharma/Grünenthal
12 Complex Regional Pain Syndrome 7MM Market Analysis
12.1 CRPS Key Findings
12.1 Complex Regional Pain Syndrome Market Size in 7MM
13 United States: Market Outlook
14 EU-5 Countries: Market Outlook
14.1 CRPS Germany Market Size
14.2 CRPS France Market Size
14.3 CRPS Italy Market Size
14.4 CRPS Spain Market Size
14.5 CRPS United Kingdom Market Size
15 CRPS Japan Market Outlook
16 CRPS Market Drivers
17 CRPS Market Barriers
18 Appendix
19 Delveinsight Capabilities
20 Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Contact us:
Shruti Thakur
[email protected]
+919650213330
SOURCE DelveInsight Business Research, LLP
These press releases may also interest you
|